Nephrotoxicity and Hematotoxicity One Year after Four Cycles of Peptide Receptor Radionuclide Therapy (PRRT)

Bernhard Nilica; Hanna Svirydenka; Josef Fritz; Christian Uprimny; Alexander Kroiss; Sabine Buxbaum; Leonhard Gruber; Margarida Rodrigues; Irene Virgolini

Meeting ReportOncology: Clinical Therapy and Diagnosis -> Clinical Therapy

Nephrotoxicity and Hematotoxicity One Year after Four Cycles of Peptide Receptor Radionuclide Therapy (PRRT)

Bernhard Nilica, Hanna Svirydenka, Josef Fritz, Christian Uprimny, Alexander Kroiss, Sabine Buxbaum, Leonhard Gruber, Margarida Rodrigues and Irene Virgolini

Journal of Nuclear Medicine May 2020, 61 (supplement 1) 307;

Bernhard Nilica

1University Hospital for Nuclear Medicine Innsbruck Austria

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Hanna Svirydenka

2Tirol Kliniken Innsbruck Austria

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Josef Fritz

3Medical University of Innsbruck Innsbruck Austria

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Christian Uprimny

4Medical University Innsbruck Innsbruck Austria

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Alexander Kroiss

5Department of Nuclear Medicine, University Clinic Innsbruck Austria

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Sabine Buxbaum

6University Hospital of nulear medicin Innsbruck Innsbruck Austria

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Leonhard Gruber

4Medical University Innsbruck Innsbruck Austria

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Margarida Rodrigues

7Department of Nuclear Medicine Innsbruck Medical University Innsbruck Austria

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Irene Virgolini

8Medical University of Innsbruck, Department of Nuc Innsbruck Austria

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Info & Metrics

Article Figures & Data

Figures

Download figure
Open in new tab
Download powerpoint

In this issue

Journal of Nuclear Medicine

Vol. 61, Issue supplement 1

May 1, 2020

Table of Contents
Index by author

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Nephrotoxicity and Hematotoxicity One Year after Four Cycles of Peptide Receptor Radionuclide Therapy (PRRT)

Message Subject (Your Name) has sent you a message from Journal of Nuclear Medicine

Message Body (Your Name) thought you would like to see the Journal of Nuclear Medicine web site.

Your Personal Message

Citation Tools

Nephrotoxicity and Hematotoxicity One Year after Four Cycles of Peptide Receptor Radionuclide Therapy (PRRT)

Bernhard Nilica, Hanna Svirydenka, Josef Fritz, Christian Uprimny, Alexander Kroiss, Sabine Buxbaum, Leonhard Gruber, Margarida Rodrigues, Irene Virgolini

Journal of Nuclear Medicine May 2020, 61 (supplement 1) 307;

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Nephrotoxicity and Hematotoxicity One Year after Four Cycles of Peptide Receptor Radionuclide Therapy (PRRT)

Bernhard Nilica, Hanna Svirydenka, Josef Fritz, Christian Uprimny, Alexander Kroiss, Sabine Buxbaum, Leonhard Gruber, Margarida Rodrigues, Irene Virgolini

Journal of Nuclear Medicine May 2020, 61 (supplement 1) 307;

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Bookmark this article

User Name *

Password *

Remember my user name & password.

Jump to section

Article
Figures & Data
Info & Metrics

No related articles found.

Google Scholar

Cited By...

No citing articles found.

Google Scholar

Oncology: Clinical Therapy and Diagnosis -> Clinical Therapy

Effect of sinomenine hydrochloride on papillary thyroid carcinoma cell when treated by radioiodine
Peptide Receptor Radionuclide Therapy as First Line Systemic Treatment in Advanced Inoperable/Metastatic Neuroendocrine Tumours
First-in-Human dose escalation of AlphaMedix^TM for Targeted Alpha-Emitter Therapy of NETs

Show more Oncology: Clinical Therapy and Diagnosis -> Clinical Therapy

Advances in Endo/Neuroendo Therapy

Not radioactive iodine-131 uptake but thyroglobulin was a prognostic factor for ablation efficacy in non-metastaticthyroid cancer
Effect of sinomenine hydrochloride on papillary thyroid carcinoma cell when treated by radioiodine

Show more Advances in Endo/Neuroendo Therapy

Main menu

User menu

Search

Nephrotoxicity and Hematotoxicity One Year after Four Cycles of Peptide Receptor Radionuclide Therapy (PRRT)

Article Figures & Data

Figures

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Oncology: Clinical Therapy and Diagnosis -> Clinical Therapy

Advances in Endo/Neuroendo Therapy

Similar Articles